Total Payments
$12,402
2024 Payments
$1,558
Companies
68
Transactions
747
Medicare Patients
19,851
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$12,314 (99.3%)
Education$87.58 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,314 | 737 | 99.3% |
| Education | $87.58 | 10 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,687 | 89 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,472 | 81 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,056 | 57 | $0 (2024) |
| PFIZER INC. | $893.67 | 66 | $0 (2024) |
| Novo Nordisk Inc | $792.27 | 53 | $0 (2024) |
| ABBVIE INC. | $732.14 | 41 | $0 (2024) |
| Lilly USA, LLC | $640.20 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $588.24 | 36 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $414.49 | 26 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $378.45 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,558 | 80 | GlaxoSmithKline, LLC. ($239.04) |
| 2023 | $1,186 | 61 | GlaxoSmithKline, LLC. ($229.53) |
| 2022 | $1,309 | 74 | GlaxoSmithKline, LLC. ($176.46) |
| 2021 | $1,622 | 100 | AstraZeneca Pharmaceuticals LP ($215.66) |
| 2020 | $989.05 | 59 | AstraZeneca Pharmaceuticals LP ($142.04) |
| 2019 | $2,379 | 151 | AstraZeneca Pharmaceuticals LP ($331.38) |
| 2018 | $1,533 | 98 | AstraZeneca Pharmaceuticals LP ($298.77) |
| 2017 | $1,828 | 124 | Boehringer Ingelheim Pharmaceuticals, Inc. ($502.62) |
All Payment Transactions
747 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Insomnia | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: UROLOGY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Endocrinology | ||||||
| 10/09/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/08/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Insulin Pump | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: VACCINES | ||||||
| 09/24/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Endocrinology | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 5,268 | 9,713 | $2.8M | $670,235 |
| 2022 | 46 | 5,464 | 13,246 | $3.1M | $707,209 |
| 2021 | 36 | 4,482 | 8,713 | $2.8M | $602,156 |
| 2020 | 37 | 4,637 | 9,771 | $8.6M | $617,450 |
Total Patients
19,851
Total Services
41,443
Medicare Billing
$2.6M
Procedure Codes
165
All Medicare Procedures & Services
165 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 379 | 1,374 | $626,283 | $116,874 | 18.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 675 | 865 | $501,620 | $114,457 | 22.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 411 | 1,520 | $167,620 | $57,780 | 34.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 359 | 930 | $195,440 | $56,544 | 28.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 694 | 887 | $186,350 | $54,707 | 29.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 205 | $166,050 | $33,492 | 20.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 262 | 465 | $75,345 | $25,146 | 33.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 371 | $131,334 | $23,134 | 17.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $65,625 | $21,475 | 32.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 167 | 169 | $50,700 | $18,264 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 158 | 159 | $55,650 | $14,033 | 25.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 129 | $67,700 | $12,886 | 19.0% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 53 | 158 | $93,852 | $12,509 | 13.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 188 | 190 | $19,000 | $11,081 | 58.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 75 | 75 | $28,125 | $10,893 | 38.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 87 | 111 | $34,410 | $9,745 | 28.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 95 | $28,500 | $8,690 | 30.5% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 47 | 50 | $31,000 | $8,031 | 25.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 47 | 47 | $21,150 | $7,426 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 44 | $24,552 | $5,886 | 24.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 27 | $13,974 | $5,331 | 38.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 88 | 90 | $22,500 | $4,841 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $15,400 | $4,586 | 29.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 13 | 79 | $19,197 | $4,245 | 22.1% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 59 | 59 | $17,700 | $3,365 | 19.0% |
About Dr. Msonthi Levine, MD
Dr. Msonthi Levine, MD is a Internal Medicine healthcare provider based in Beaumont, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962430413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Msonthi Levine, MD has received a total of $12,402 in payments from pharmaceutical and medical device companies, with $1,558 received in 2024. These payments were reported across 747 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($12,314).
As a Medicare-enrolled provider, Levine has provided services to 19,851 Medicare beneficiaries, totaling 41,443 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 165 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Beaumont, TX
- Active Since 06/30/2006
- Last Updated 04/16/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962430413
Products in Payments
- FARXIGA (Drug) $1,144
- TRELEGY ELLIPTA (Drug) $739.82
- XARELTO (Drug) $536.86
- Ozempic (Drug) $379.93
- ELIQUIS (Drug) $355.96
- JARDIANCE (Drug) $317.55
- TRULICITY (Drug) $299.27
- ANORO (Drug) $295.84
- ENTRESTO (Drug) $287.42
- QULIPTA (Drug) $238.62
- AREXVY (Drug) $235.00
- STIOLTO RESPIMAT (Drug) $214.12
- BREZTRI (Drug) $206.09
- VRAYLAR (Drug) $183.69
- XIFAXAN (Drug) $183.25
- EMGALITY (Drug) $182.73
- TRINTELLIX (Drug) $157.47
- CHANTIX (Drug) $156.41
- Rybelsus (Drug) $155.21
- STIOLTO (Drug) $141.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Beaumont
Dr. Salem Salem, M.d, M.D
Internal Medicine — Payments: $109,385
Internal Medicine $109,385
Mark Fasulo, Md, MD
Internal Medicine — Payments: $109,209
Internal Medicine $109,209
Dr. Russell Perry, Md, MD
Internal Medicine — Payments: $100,450
Internal Medicine $100,450
Dr. William Burkes, M.d, M.D
Internal Medicine — Payments: $97,221
Internal Medicine $97,221
Dr. Allen Mcgrew, D.o, D.O
Internal Medicine — Payments: $27,220
Internal Medicine $27,220
Dr. Mohammad Alghrouz, Md, MD
Internal Medicine — Payments: $12,639
Internal Medicine $12,639